Poulos C, Ng X, Mansfield C, Rosenberg S, Peay H, Lee J, Irony T, Ho M. Logical soundness in a discrete choice experiment study of benefit risk preferences. Presented at the ISPOR 2022 Conference; May 15, 2022. Washington, DC. [abstract] Value Health. 2022 Jun; 25(6 S1).
Sutphin J, DiSantostefano R, Leach CA, Hauber B, Mansfield C. Preferences, optimism, and numeracy: an exploration into the use of psychological patient-reported outcome instruments in a preference survey. Presented at the 2020 ISPOR Virtual Conference; May 19, 2020. [abstract] Value Health. 2020 May 1; 23(Suppl 1):S328. doi: 10.1016/j.jval.2020.04.094
Basarir H, Pollard D, Brennan A, Elliott J, Heller S, Campbell MJ. The potential value of ongoing support in type-1 diabetes mellitus with dafneplus: exploratory pre-trial cost-effectiveness analysis on proposed trial end-point target for 12-month Hba1c improvement. Presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam, The Netherlands. [abstract] Value Health. 2014 Nov; 17(7):A350. doi: 10.1016/j.jval.2014.08.725
Martín-Merino E, Fortuny J, Rivero E, García-Rodríguez LA. Risk factors for incident diabetic retinopathy in type II diabetes in UK primary care. Presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; June 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21(Suppl 3):S3.
Martín-Merino E, Fortuny J, Rivero E, García-Rodríguez LA. Validation of diabetic retinopathy and maculopathy diagnoses recorded in a United Kingdom primary care database. Presented at the 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21(Suppl 3):S164-5.